Effect of CFIm68 knockdown on RNA polymerase II transcription.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
02 Sep 2019
Historique:
received: 20 06 2019
accepted: 21 08 2019
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 24 1 2020
Statut: epublish

Résumé

Transcription of eukaryotic protein-coding genes by RNA polymerase II (pol II) is highly regulated at initiation, elongation and termination. Transcription is also coordinated with co-transcriptional processing of the emerging pre-mRNA by capping, splicing, and cleavage and polyadenylation. Polyadenylation (poly(A)) site recognition, which defines the end of the mRNA, relies on the cleavage and polyadenylation (CPA) complex. It was previously observed that knocking-down proteins of the CPA complex affects not only recognition of the poly(A) site but also results in increased pausing of pol II at the beginning of genes. This finding suggests that the CPA complex plays a role in regulating pol II turnover after transcription initiation. To explore this possibility, we knocked-down a subunit of the cleavage factor I (CFIm), CFIm68, which is part of the CPA complex and involved in alternative polyadenylation, and performed pol II ChIP-seq in absence or presence of a transcription elongation inhibitor. In addition, we performed pol II ChIP-qPCR on a subset of protein coding genes after knocking down CFIm68.

Identifiants

pubmed: 31477156
doi: 10.1186/s13104-019-4582-8
pii: 10.1186/s13104-019-4582-8
pmc: PMC6720987
doi:

Substances chimiques

cleavage factor Im, human 0
mRNA Cleavage and Polyadenylation Factors 0
RNA Polymerase II EC 2.7.7.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

554

Subventions

Organisme : Wellcome Trust
ID : WT106134AIA
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C38302/A13012
Pays : United Kingdom

Références

Nucleic Acids Res. 2006;34(21):6264-71
pubmed: 17098938
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10062-7
pubmed: 20479262
Genes Cells. 2010 Sep 1;15(9):1003-13
pubmed: 20695905
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Genome Res. 2012 Jun;22(6):1173-83
pubmed: 22454233
Mol Cell. 2012 May 11;46(3):311-24
pubmed: 22483619
Genes Dev. 1989 Nov;3(11):1711-24
pubmed: 2558045
Nat Struct Mol Biol. 2015 May;22(5):396-403
pubmed: 25849141
Cell. 2015 Apr 23;161(3):526-540
pubmed: 25910207
Genes Dev. 2015 May 1;29(9):889-97
pubmed: 25934501
Transcription. 2015;6(5):79-90
pubmed: 26399478
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Biochem Soc Trans. 2016 Aug 15;44(4):1051-7
pubmed: 27528751
Mol Cell. 2018 Jan 4;69(1):62-74.e4
pubmed: 29276085
BMC Res Notes. 2018 Dec 14;11(1):894
pubmed: 30547832
J Biol Chem. 1996 Mar 15;271(11):6107-13
pubmed: 8626397

Auteurs

Michael Tellier (M)

Sir William Dunn School of Pathology, University of Oxford, South Park Roads, Oxford, OX1 3RE, UK. michael.tellier@path.ox.ac.uk.

Jessica G Hardy (JG)

Sir William Dunn School of Pathology, University of Oxford, South Park Roads, Oxford, OX1 3RE, UK.

Chris J Norbury (CJ)

Sir William Dunn School of Pathology, University of Oxford, South Park Roads, Oxford, OX1 3RE, UK.

Shona Murphy (S)

Sir William Dunn School of Pathology, University of Oxford, South Park Roads, Oxford, OX1 3RE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH